Last reviewed · How we verify
BardetBiedl syndrome
Approved treatments
- Imcivree · Rhythm
Imcivree works by activating the melanocortin 4 receptor, a protein that helps regulate appetite and metabolism.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- BardetBiedl syndrome patent landscape — cliff calendar, originator estates, attackable patents
- BardetBiedl syndrome treatment landscape brief
- BardetBiedl syndrome treatment updates RSS
Frequently asked questions about BardetBiedl syndrome
What drugs treat BardetBiedl syndrome?
Tracked treatments include Imcivree.
What is the treatment for BardetBiedl syndrome?
Standard treatment for BardetBiedl syndrome includes Imcivree. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: BardetBiedl syndrome patent cliff · BardetBiedl syndrome CI report
- Treatment: Imcivree · Rhythm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing